Renal Cancer - Results from #6660

Diffuse bone marrow sarcoid-like reaction associated with renal cell carcinoma - Abstract October 8, 2014

Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: A case report - Abstract October 7, 2014

Thermal ablation in renal cell carcinoma management: A comprehensive review - Abstract October 7, 2014

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma - Abstract October 7, 2014

Adjuvant therapy for renal cell carcinoma - Abstract October 7, 2014

Sunitinib, pazopanib or sorafenib for the treatment of patients with late-relapsing (>5 years) metastatic renal cell carcinoma - Abstract October 4, 2014

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries - Abstract October 3, 2014

Risk evaluation of selective renal arterial embolization in the treatment of delayed hemorrhage from renal artery pseudoaneurysm after partial nephrectomy - Abstract October 2, 2014

Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial - Abstract October 2, 2014

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for T1 renal cell carcinoma - Abstract October 2, 2014

Dietary fiber intake and risk of renal cell carcinoma: Evidence from a meta-analysis - Abstract October 2, 2014

The role of embolization in reducing the complications of cryoablation in renal cell carcinoma - Abstract September 30, 2014

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma following treatment failure with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor - Abstract September 30, 2014

Current practices in the management of adverse events associated with targeted therapies for advanced renal cell carcinoma: A national survey of oncologists - Abstract September 29, 2014

Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007 - Abstract September 29, 2014

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma - Abstract September 25, 2014

Best practices recommendations in the application of immunohistochemistry in the kidney tumors: Report from the International Society of Urologic Pathology consensus conference - Abstract September 25, 2014

Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis - Abstract September 23, 2014

Pathological characteristics and radiographic correlates of complex renal cysts - Abstract September 23, 2014

The necessity of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma using antiangiogenic targeted therapy after interferon alfa-2b - Abstract September 22, 2014

Page 334 of 456